世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000028595

スウェーデンにおける医療、規制、および医療費償還制度の展望

GlobalData

Sweden - Healthcare, Regulatory and Reimbursement Landscape

発刊日2020/12/31

言語英語

体裁PDF/146ページ

「PDF」版146ページ

0000028595

スウェーデンにおける医療、規制、および医療費償還制度の展望
Sweden - Healthcare, Regulatory and Reimbursement Landscape

1,995 USD

※商品のお問い合わせはカートに入れていただくと可能です。

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、スウェーデンにおける医療、規制、および医療費償還制度の展望に関する情報や分析に不可欠な情報を提供し、医療市場における主要動向を明らかにします。また、人口動態、規制、医療費償還制度の展望、および医療インフラに関する見識を提供します。さらに、製薬および医療機器市場の動向やセグメントに関する貴重な情報を提供します。

最も重要なこととして、本レポートは、製薬および医療機器市場のトレンドとセグメンテーションに対する貴重な洞察を提供します。GlobalData社の業界専門家チームによる独自のデータベース、二次調査、社内分析からのデータと情報を使用して構築されています。

スウェーデンの医薬品市場は、スウェーデンクローナ換算で2012年には361.1億クローナと評価され、2019年には4.78%のCAGRで500.9億クローナに増加しました。米ドル換算では、2012年には53.3億ドルと評価されていましたが、2019年には0.09%のマイナスCAGRで減少して53億ドルとなりました。市場価値は米ドルベースでは横ばいで、2024年には52.7億ドルに達すると予測されています。医薬品市場の成長は、高齢人口の増加、糖尿病や肥満などの生活習慣病の増加、心血管疾患、脳卒中、がんなどの慢性疾患の有病率の増加に起因しています。ジェネリック医薬品の代替と低価格がスウェーデンの医薬品市場の成長の障壁となっています。

■調査範囲

  • 市場規模、市場セグメント、主要推進要因、および障壁など、スウェーデンにおける製薬および医療機器市場の概説
  • 主要企業のプロファイルとSWOT分析
    ➣ 主要製薬企業:Pfizer、AstraZeneca、Fresenius Kabi、Octapharma、Sobi
    ➣ 主要医療機器企業:Abbott、Medtronic、DePuy Synthes、Alcon、Getinge
  • COVID-19疫学、COVID-19の影響とヘルスケア市場の進展、HealthTech展望、償還と規制展望に関する洞察に富んだレビュー、国のヘルスケア償還プロセス、規制当局、新薬と医療機器の承認プロセスの詳細をカバーする分析
  • ヘルスケア償還プロセス、規制機関、新薬および医療機器の承認プロセスの詳細を含む、償還および規制状況の洞察を深めたレビュー
  • 最近の医療政策、医療インフラおよび医療費に関する情報
  • スウェーデンの医療市場における成長の機会と成長の課題の概要

レポート詳細

目次

1. Table of Contents
1.1 LIST OF FIGURES
1.2 LIST OF TABLES

2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Swedish Healthcare Market
2.3 Key Highlights: Healthcare Startups in Sweden
2.4 Key Events: Swedish Healthcare Timeline, 2014-2020
2.5 Key Events: Swedish Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Sweden, 2019

3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Sweden
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Sweden
3.7 COVID-19 Epidemiology, Sweden
3.8 COVID-19 Impact and Developments in the Healthcare Market, Sweden
3.9 COVID-19 Clinical Trials Landscape, Sweden
3.10 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers

6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Sweden, 2019-2020
6.2 Deal Analysis: Medical Device Market, Sweden, 2019-2020

7. HealthTech Landscape
7.1 HealthTech Deals Landscape, Sweden
7.2 Key HealthTech Deals, Sweden
7.3 Adoption of Technology in Healthcare, Sweden
7.4 Regulatory Scenario Covering Use of Technology in Healthcare, Sweden
7.5 HealthTech Landscape: Benefits and Risks, Sweden

8. Market Access
8.1 Overview of Healthcare System, Sweden
8.2 Reimbursement Process, Sweden
8.3 Overview of Insurance Providers, Sweden
8.4 Healthcare Spending and Medicine Price Index, Sweden
8.5 Pricing Policies, Sweden
8.6 Regulatory Landscape, Sweden
8.6.1 Overview of Regulatory Agencies
8.6.2 Marketing Authorization for Pharmaceutical Products, EU
8.6.3 Marketing Authorization for Pharmaceutical Products, National Procedure, Sweden
8.6.4 Marketing Authorization for Pharmaceutical Products, Centralized Procedure, Sweden
8.6.5 Marketing Authorization for Pharmaceutical Products, Decentralized Procedure, Sweden
8.6.6 Marketing Authorization for Pharmaceutical Products, Mutual Recognition Procedure, Sweden
8.6.7 Market Authorization for Medical Devices, Sweden
8.6.8 Intellectual Property Rights, Patent, Sweden
8.6.9 Intellectual Property Rights, European Patent, Sweden
8.6.10 Intellectual Property Rights, Unitary Patent, Sweden
8.6.11 Intellectual Property Rights, Trademark, Sweden
8.6.12 Clinical Trials Regulation, Sweden
8.6.13 Pharmaceutical Clinical Trials Landscape, Sweden
8.6.14 Medical Devices Clinical Trials Landscape, Sweden
8.6.15 Licensing Process for Pharmaceutical Manufacturing, Sweden
8.6.16 Licensing Process for Pharmaceutical Exports and Imports
8.6.17 Pharmaceutical Advertisement Regulations, Sweden
8.6.18 Labeling and Packaging Regulations, Sweden

9. Country Healthcare Landscape
9.1 Swedish Healthcare Policy Highlights
9.2 Healthcare Facilities, Sweden
9.3 Healthcare Parameters, Sweden
9.4 Life Expectancy and Immunization Rate, Sweden
9.5 Environmental Health, Sweden
9.6 Healthcare Personnel, Sweden
9.7 Disease Burden, Sweden
9.8 Healthcare Expenditure, Sweden

10 Trade Associations, Sweden

11 Trade Fairs, Sweden

12 Opportunities and Challenges

13 Appendix

List of Tables
Table 1: Approved Biosimilars, EU, 2019-2020
Table 2: Pharmaceutical Market, Sweden, Sales of Patented Drug Products (by Major Therapeutic Class) ($M), 2019
Table 3: COVID-19 Indicators (Number of Cases), Global and Sweden, 2020
Table 4: COVID-19 IVD Products, Sweden, 2020
Table 5: Medical Device Market, Sweden, Major Segments ($M), 2019
Table 6: Orthopedic Devices Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 7: Cardiovascular Devices Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 8: General Surgery Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 9: Wound Care Management Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 10: Diabetes Care Devices Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 11: Role of the Healthcare Authorities, Sweden, 2020
Table 12: Benefits Associated with SSIA, Sweden, 2017
Table 13: Pricing of Medicines at Different Levels, Sweden, 2017
Table 14: MA Application Type and Fees, Sweden, 2019
Table 15: MA Annual Fees, Sweden, 2019
Table 16: Medical Devices Registration Fees, Sweden, 2020
Table 17: Patent Fees, Sweden, 2020
Table 18: Trademark Fees, Sweden, 2020
Table 19: Advertising Regulations, Sweden, 2020
Table 20: Advertising of Pharmaceutical Products Through Other Mass Media, Sweden, 2020
Table 21: Label of Outer Packaging And Medicine Containers, Sweden, 2020
Table 22: Label of Pharmaceutical Blister, Sweden, 2020
Table 23: Label of Small Pharmaceutical Packaging, Sweden, 2020

List of Figures
Figure 1: Pharmaceutical Market, Sweden, Revenue ($B), 2012-2019
Figure 2: Medical Device Market, Sweden, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Sweden, 2020
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, Sweden, 2019
Figure 7: Pharmaceutical Market, Sweden, Revenue ($B), 2012-2019
Figure 8: Pharmaceutical Market, Sweden, Revenue Forecast ($B), 2020-2024
Figure 9: Pharmaceutical Exports ($B), Sweden, 2012-2019
Figure 10: Top Export Partners, Sweden, 2019
Figure 11: Pharmaceutical Imports ($B), Sweden, 2012-2019
Figure 12: Top Import Partners, Sweden, 2019
Figure 13: Pharmaceutical Supply Channel, Sweden, 2019
Figure 14: Pharmacy Market Share Based on the Number of Pharmacies, Sweden, 2012-2019
Figure 15: OTC Market, Sweden, Revenue ($B), 2012-2019
Figure 16: OTC Market by Drug Category, Sweden, Revenue ($M), 2019
Figure 17: Pharmaceutical Market, Sweden, Sales of Patented Drug Products (by Major Therapeutic Class), 2019
Figure 18: COVID-19 (Cases), Sweden, 2020
Figure 19: COVID-19 (Deaths), Sweden, 2020
Figure 20: COVID-19 Clinical Trials Count (by Trial Status), Sweden, 2020
Figure 21: COVID-19 Clinical Trials Count (by Phase), Sweden, 2020
Figure 22: Top Five COVID-19 Clinical Trials Sponsors (by Count), Sweden, 2020
Figure 23: Medical Device Market, Sweden, Revenue ($B), 2015-2020
Figure 24: Medical Device Market, Sweden, Revenue Forecast ($B), 2021-2025
Figure 25: Medical Device Market, Sweden, Major Segments (%), 2019
Figure 26: Orthopedic Devices Market, Sweden, Revenue ($M), 2015-2022
Figure 27: Orthopedic Devices Market, Sweden, Market Share of Major Players (%), 2019
Figure 28: Cardiovascular Devices Market, Sweden, Revenue ($M), 2015-2022
Figure 29: Cardiovascular Devices Market, Sweden, Market Share of Major Players (%), 2019
Figure 30: General Surgery Market, Sweden, Revenue ($M), 2015-2022
Figure 31: General Surgery Market, Sweden, Market Share of Major Players (%), 2019
Figure 32: Wound Care Management Market, Sweden, Revenue ($M), 2015-2022
Figure 33: Wound Care Management Market, Sweden, Market Share of Major Players (%), 2019
Figure 34: Diabetes Care Devices Market, Sweden, Revenue ($M), 2015-2022
Figure 35: Diabetes Care Devices Market, Sweden, Market Share of Major Players (%), 2019
Figure 36: Diagnostic Market, Sweden, Revenue ($M), 2015-2020
Figure 37: Diagnostic Market, Sweden, Revenue ($M), 2021-2025
Figure 38: Medical Devices Market, Revenue ($B) of Major Companies, Sweden, 2019
Figure 39: Deal Value and Deal Count, Pharmaceutical Market, Sweden, 2019-2020
Figure 40: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Sweden, 2019-2020
Figure 41: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Sweden, 2019-2020
Figure 42: Top Five Therapy Areas (by Deal Value), Pharmaceutical Market, Sweden, 2019-2020
Figure 43: Top Five Therapy Areas (by Deal Number), Pharmaceutical Market, Sweden, 2019-2020
Figure 44: M&A Deals by Therapy Area, Pharmaceutical Market, Sweden, 2019-2020 (by Value ($M) and Number)
Figure 45: PE Deals by Therapy Area, Pharmaceutical Market, Sweden, 2019-2020 (by Value ($M) and Number)
Figure 46: VC Deals by Therapy Area, Pharmaceutical Market, Sweden, 2019-2020 (by Value ($M) and Number)
Figure 47: Medical Devices Market Deals (by Deal Value, $M), Sweden, 2019-2020
Figure 48: Medical Devices Market Deals (by Deal Count), Sweden, 2019-2020
Figure 49: Medical Devices Market Deals Share (by Deal Value), Sweden, 2019-2020
Figure 50: Medical Devices Market Deals Share (by Deal Count), Sweden, 2019-2020
Figure 51: Medical Devices, Top Therapy Area (by Deal Value), Sweden, 2019-2020

この商品のレポートナンバー

0000028595

TOP